市场调查报告书
商品编码
1612249
医疗保健人工智慧市场:按技术、服务、应用程式和最终用户划分 - 全球预测 2025-2030Artificial Intelligence in Healthcare Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End User - Global Forecast 2025-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年,人工智慧在医疗保健市场的价值为259.1亿美元,预计到2024年将达到324.8亿美元,复合年增长率为26.95%,到2030年将达到1377.4亿美元。
人工智慧 (AI) 在医疗保健领域的应用范围广泛,例如诊断、个人化治疗和预测分析。目的是透过利用资料主导的见解和自动化日常业务来改善患者的治疗结果。由于对高效医疗保健解决方案的需求不断增长、患者资料量不断增加以及降低营运成本的需要,人工智慧是必要的。主要应用包括自动影像分析、追踪疾病爆发的预测分析、个人化医疗和虚拟助理。最终用途包括希望改善患者照护、简化工作流程和促进预防性健康措施的医院、研究机构和保险公司。
主要市场统计 | |
---|---|
基准年[2023] | 259.1亿美元 |
预测年份 [2024] | 324.8亿美元 |
预测年份 [2030] | 1377.4亿美元 |
复合年增长率(%) | 26.95% |
市场成长受到机器学习演算法的进步、数位健康解决方案的日益采用以及政府支持政策的影响。 COVID-19 疫情的爆发进一步加速了远端医疗和人工智慧的融合,带来了巨大的成长机会。医疗保健人工智慧新兴企业和成熟的科技巨头正在大力投资研发,为慢性病管理和病患监测的创新解决方案铺路。然而,资料隐私问题、高昂的初始成本以及缺乏熟练的人工智慧专业人员等挑战可能会阻碍成长。此外还存在监管障碍和道德考虑。人工智慧系统与现有医疗保健IT基础设施之间的互通性问题进一步限制了无缝部署。
在创新方面,人工智慧驱动的药物发现、个人化基因组医学以及透过穿戴式技术进行即时健康监测等领域有望带来巨大变化。开发人员应专注于与医疗保健提供者的伙伴关係伙伴关係,共同开发客製化的人工智慧解决方案。投资医疗保健工作者的人工智慧素养和培训计划可以缩小技能差距并促进更顺利的技术采用。同样,加强强有力的资料管治和隐私保护可以解决相关人员的担忧并增强对人工智慧采用的信心。总体而言,在技术进步和对以患者为中心的护理日益浓厚的兴趣的推动下,人工智慧医疗保健市场仍然充满活力,这对于愿意应对其固有复杂性的相关人员来说是一个绝佳的机会。
市场动态:对医疗保健市场快速发展的人工智慧的关键市场洞察
医疗保健领域的人工智慧市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助消费行为及其对製造业的影响。
波特五力:驾驭医疗保健人工智慧市场的策略工具
波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。
PESTLE分析:了解医疗保健市场人工智慧的外部影响
外部宏观环境因素在塑造医疗保健市场人工智慧的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。
市场占有率分析 了解医疗保健人工智慧市场的竞争格局
对医疗保健市场人工智慧的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。
FPNV 医疗保健市场人工智慧供应商定位矩阵绩效评估
FPNV 定位矩阵是评估医疗保健市场人工智慧供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。
策略分析与建议,规划医疗保健市场人工智慧的成功之路
对于旨在加强其在全球市场的影响力的公司来说,对医疗保健市场中的人工智慧进行策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。
1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。
2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。
3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。
4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。
5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。
1.目前的市场规模和未来的成长预测是多少?
2. 哪些产品、区隔市场和地区提供最佳投资机会?
3.塑造市场的主要技术趋势和监管影响是什么?
4.主要厂商的市场占有率和竞争地位如何?
5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?
The Artificial Intelligence in Healthcare Market was valued at USD 25.91 billion in 2023, expected to reach USD 32.48 billion in 2024, and is projected to grow at a CAGR of 26.95%, to USD 137.74 billion by 2030.
The scope of artificial intelligence (AI) in healthcare encompasses a broad range of applications, including diagnostics, treatment personalizations, and predictive analytics. It aims to enhance patient outcomes by leveraging data-driven insights and automating routine tasks. AI is necessitated by the increasing demand for efficient healthcare solutions, rising patient data volumes, and the need to reduce operational costs. Key applications include automated imaging analysis, predictive analytics for disease outbreak tracking, personalized medicine, and virtual health assistants. End-use spans hospitals, research institutions, and insurance companies aiming to improve patient care, streamline workflows, and foster preventive healthcare measures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.91 billion |
Estimated Year [2024] | USD 32.48 billion |
Forecast Year [2030] | USD 137.74 billion |
CAGR (%) | 26.95% |
Market growth is influenced by advancements in machine learning algorithms, increasing adoption of digital health solutions, and supportive government policies. The integration of AI with telemedicine, further accelerated by the COVID-19 pandemic, presents significant growth opportunities. Healthcare AI startups and established tech giants are investing heavily in R&D, paving the way for innovative solutions addressing chronic disease management and patient monitoring. However, challenges such as data privacy concerns, high initial costs, and a shortage of skilled AI professionals may hinder growth. There are also regulatory hurdles and ethical considerations. Interoperability issues between AI systems and existing healthcare IT infrastructures further limit seamless adoption.
In terms of innovation, areas like AI-driven drug discovery, personalized genomics, and real-time health monitoring via wearable technology promise substantial transformation. Businesses should focus on partnerships and collaborations with healthcare providers to co-develop tailored AI solutions. Investing in AI literacy and training programs for healthcare professionals can bridge skill gaps, ensuring smoother technology adoption. Similarly, reinforcing robust data governance and privacy protection measures can alleviate stakeholders' concerns, fostering trust in AI deployments. Overall, the AI healthcare market remains dynamic, driven by technology advancements and a growing focus on patient-centric care, offering ripe opportunities for stakeholders willing to navigate its inherent complexities.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Healthcare Market
The Artificial Intelligence in Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Healthcare Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Healthcare Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Healthcare Market
A detailed market share analysis in the Artificial Intelligence in Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Healthcare Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Healthcare Market
A strategic analysis of the Artificial Intelligence in Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Ada Health GmbH, AiCure, LLC, AllStripes Research Inc., Aspen Technology Inc. by Emerson Electric Co., Atomwise Inc., Augmedix, Inc., Babylon Healthcare Services Ltd., Behold.ai Technologies Limited, Binah.ai, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Clarius Mobile Health Corp., Clinithink Limited, ClosedLoop.ai Inc., Corti ApS, Cyrcardia Asia Limited, Datature.io, Deep Genomics Incorporated, Diabeloop SA, Enlitic, Inc., GE Healthcare, General Vision Inc., Google, LLC by Alphabet, Inc., iCarbonX, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medasense Biometrics Ltd., Microsoft Corporation, Modernizing Medicine, Inc., Nanox Imaging Ltd., NetBase Quid, Inc., Novo Nordisk A/S, NVIDIA Corporation, Oncora Medical, Oracle Corporation, Owkin, Inc., Oxipit.ai, R1 RCM, Inc., Recursion Pharmaceuticals, Sanofi SA, Sensely, Inc., Shanghai Yitu Technology Co., Ltd., Siemens Healthineers AG, SkinvVision B.V., Subtle Medical, Inc., Tempus Labs, Inc., Turbine Ltd., and Woebot Health.
Market Segmentation & Coverage
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?